Topic: intraocular lenses
Novartis’ Alcon unit is picking up 2016 Fierce 15 company PowerVision in a $285 million deal for its flexible, fluid-based intraocular lens.
J&J Vision launched a new intraocular lens for cataract treatment in Europe, designed to provide vision at both intermediate and far distances.
After over four years in development, Verily and Alcon have decided to mothball their work on a smart contact lens to measure glucose levels.
The Chinese medical device company picked up a local approval for its products last year, setting it up to service the country’s cataract patients.
Novartis’ Alcon earned a CE mark for its automated, disposable, preloaded intraocular lens delivery system.
Though PowerVision has been around for more than a decade, this past year has been a catalyst for the company’s goal of clearing a path for its innovative fluid-based intraocular lens in what is a crowded market for ophthalmological devices.
Abbott has earned FDA approval for its Tecnis Symfony Intraocular Lenses for the treatment of cataracts. The approval includes the Tecnis Symfony Toric IOL, a version of the lenses that are made for people with astigmatism.